본문 바로가기
KERD
논문KCI 등재

Transient splenial lesions of the corpus callosum and infectious diseases

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Transient splenial lesion of the corpus callosum can be observed in various diseases such as cancer, drug use, metabolic disorders, and cerebrovascular disorders, as well as in patients with infectious diseases. During the coronavirus disease 2019 (COVID-19) pandemic, there were increasing reports of these lesions being detected on brain imaging tests performed in patients with neurological symptoms. On brain magnetic resonance imaging, findings suggestive of cytotoxic edema are observed in the splenium; these are known to disappear with improvement of clinical symptoms. Cytokinopathy caused by infection increases the permeability of the blood–brain barrier and activates the glial cells of the brain to induce cytotoxic edema. Most patients have a good prognosis. The causes, mechanism, diagnosis, treatment and prognosis of transient splenial lesions of the corpus callosum will be summarized in this review.

Abstract

Transient splenial lesion of the corpus callosum can be observed in various diseases such as cancer, drug use, metabolic disorders, and cerebrovascular disorders, as well as in patients with infectious diseases. During the coronavirus disease 2019 (COVID-19) pandemic, there were increasing reports of these lesions being detected on brain imaging tests performed in patients with neurological symptoms. On brain magnetic resonance imaging, findings suggestive of cytotoxic edema are observed in the splenium; these are known to disappear with improvement of clinical symptoms. Cytokinopathy caused by infection increases the permeability of the blood–brain barrier and activates the glial cells of the brain to induce cytotoxic edema. Most patients have a good prognosis. The causes, mechanism, diagnosis, treatment and prognosis of transient splenial lesions of the corpus callosum will be summarized in this review.

참고문헌 (34)

  1. Knyazeva MG, "Splenium of corpus callosum : patterns of interhemispheric interaction in children and adults", Neural Plast, 2013, pp.639430~ (2013)
  2. Raybaud C, "The corpus callosum, the other great forebrain commissures, and the septum pellucidum : anatomy, development, and malformation", Neuroradiology, 52, pp.447~477 (2010)
  3. Takanashi J, "Reversible restricted diffusion of entire corpus callosum", J Neurol Sci, 247, pp.101~104 (2006)
  4. Starkey J, "Cytotoxic lesions of the corpus callosum that show restricted diffusion : mechanisms, causes, and manifestations", Radiographics, 37, pp.562~576 (2017)
  5. Garcia-Monco JC, "Reversible splenial lesion syndrome(RESLES) : what's in a name", J Neuroimaging, 21, pp.e1~e14 (2011)
  6. Takanashi J, "Widening spectrum of a reversible splenial lesion with transiently reduced diffusion", AJNR Am J Neuroradiol, 27, pp.836~838 (2006)
  7. Bulakbasi N, "Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis", encephalopathy, 2006, pp.27, 1983~1986
  8. Singh P, "Transient splenial lesion : further experience with two cases", Indian J Radiol Imaging, 20, pp.254~257 (2010)
  9. Malhotra HS, "Boomerang sign : clinical significance of transient lesion in splenium of corpus callosum", Ann Indian Acad Neurol, 15, pp.151~157 (2012)
  10. 조정선, "Mild Encephalopathy with Reversible Lesion in the Splenium of the Corpus Callosum and Bilateral Frontal White Matter", Journal of Clinical Neurology, 3(1), pp.53~56 (2007), 대한신경과학회
  11. Kakadia B, "Mild encephalopathy with reversible splenium lesion(MERS)in a patient with COVID-19", J Clin Neurosci, 79, pp.272~274 (2020)
  12. Kahilogullari G, "Arterial vascularization patterns of the splenium : an anatomical study", Clin Anat, 26, pp.675~681 (2013)
  13. Mathews MS, "Van Wagenen and the first corpus callosotomies for epilepsy", J Neurosurg, 108, pp.608~613 (2008)
  14. Lin D, "Reversible splenial lesions presenting in conjunction with febrile illness : a case series and literature review", Emerg Radiol, 24, pp.599~604 (2017)
  15. Talukder NT, "Mild encephalitis", encephalopathy with a reversible splenial lesion associated with systemic Mycoplasma pneumoniae infection in North America : a case report, 2022, pp.16, 74~
  16. Mawatari M, "Mild encephalitis", encephalopathy with a reversible splenial lesion due to Plasmodium falciparum malaria : a case report, 2018, pp.46, 37~
  17. Sathananthasarma P, "Reversible splenial lesion syndrome associated with dengue fever : a case report", BMC Res Notes, 11, pp.412~ (2018)
  18. Varol F, "Can plasma exchange therapy be an option for the treatment of SARS-CoV-2 related splenial lesion syndrome : two cases from the pediatric intensive care unit", Transfus Apher Sci, pp.103491~ (2022)
  19. Arıkan FA, "Isolated corpus callosum lesion associated with cytokine storm in COVID-19", Proc(Bayl Univ Med Cent), 35, pp.337~338 (2022)
  20. DE Oliveira FA, "Transient lesion in the splenium of the corpus callosum associated with COVID-19", Arq Neuropsiquiatr, 78, pp.738~ (2020)
  21. Sawlani V, "COVID-19-related intracranial imaging findings : a large single-centre experience", Clin Radiol, 76, pp.108~116 (2021)
  22. McLeod NA, "Normal and abnormal morphology of the corpus callosum", Neurology, 37, pp.1240~1242 (1987)
  23. Park MK, "Lesions in the splenium of the corpus callosum : clinical and radiological implications", Neurol Asia, 19, pp.79~88 (2014)
  24. Chen WX, "Reversible splenial lesion syndrome in children : retrospective study and summary of case series", Brain Dev, 38, pp.915~927 (2016)
  25. 백신혜, "Reversible Splenium Lesion of the Corpus Callosum in Hemorrhagic Fever with Renal Failure Syndrome", Journal of Korean Medical Science, 25(8), pp.1244~1246 (2010), 대한의학회
  26. Tada H, "Clinically mild encephalitis", encephalopathy with a reversible splenial lesion, 2004, pp.63, 1854~1858
  27. Doherty MJ, "Clinical implications of splenium magnetic resonance imaging signal changes", Arch Neurol, 62, pp.433~437 (2005)
  28. Takanashi J, "Encephalopathy with a reversible splenial lesion is associated with hyponatremia", Brain Dev, 31, pp.217~220 (2009)
  29. Miyata R, "Oxidative stress in patients with clinically mild encephalitis", encephalopathy with a reversible splenial lesion(MERS), 2012, pp.34, 124~127
  30. Motobayashi M, "Subclinical neuroaxonal damage in patients with clinically mild encephalitis", encephalopathy with a reversible splenial lesion, 2017, pp.74, e3~e4
  31. Moritani T, "Diffusion-weighted imaging of acute excitotoxic brain injury", AJNR Am J Neuroradiol, 26, pp.216~228 (2005)
  32. Conklin J, "Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19", J Neurol Sci, 421, pp.117308~ (2021)
  33. Sparr SA, "Infarction of the splenium of the corpus callosum in the age of COVID-19 : a snapshot in time", Stroke, 51, pp.e223~e226 (2020)
  34. Chougar L, "Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations", Radiology, 297, pp.E313~E323 (2020)

관련 논문AI추천

이 간행물의 다른 논문 (26건)